Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

ENSG earnings analysis

Filed July 27, 2026 · Our reading of the company's report

The latest report

Ensign delivered strong Q2 growth, with revenue of $1.440 billion (+17.3% year over year) and diluted EPS of $1.68 (+16.7%), supported by acquisitions, higher occupancy, and patient acuity. Operating margin held at 8.5%…

Read full summary

Ensign delivered strong Q2 growth, with revenue of $1.440 billion (+17.3% year over year) and diluted EPS of $1.68 (+16.7%), supported by acquisitions, higher occupancy, and patient acuity. Operating margin held at 8.5% year over year but declined from 9.0% in Q1, reflecting higher G&A and depreciation associated with expansion and system implementation. Operating cash flow remained robust at $272.1 million for the first six months, though acquisitions and buybacks reduced cash to $262.3 million. The central risks are Medicaid-policy exposure, the DOJ CID and active reimbursement reviews, and elevated regulatory scrutiny of SNFs.

Read the original on SEC.gov

Where revenue came from

The business segments reported by the company.

Skilled services revenue 92.7% All Other revenue 4.3% Standard Bearer rental revenue 3.0%

Shares of the segments disclosed in this filing, largest first.

Reported figures

Earnings per share
$1.68
Operating margin
8.5%

What stood out

  • Double-digit revenue growth and EPS advance

    Q2 revenue rose 17.3% year over year to $1.440 billion and increased 3.6% sequentially from $1.390 billion in Q1 2026. Diluted GAAP EPS increased 16.7% year over year to $1.68 and edged up from $1.67 in Q1.

  • Margins stable year over year

    Operating margin was 8.5%, unchanged from Q2 2025's 8.5%, while sequentially it declined 50 basis points from 9.0% in Q1 2026. Skilled-services cost of services improved 60 basis points year over year to 78.9% of revenue, aided by lower agency expense and ancillary efficiencies.

  • Broad skilled-services growth

    Skilled-services revenue increased $206.3 million, or 17.6%, to $1.380 billion. Same-facility revenue grew 6.6% to $988.3 million, transitioning-facility revenue grew 6.1% to $197.4 million, and recently acquired facilities added $133.5 million of growth.

  • REIT segment scales rapidly

    Standard Bearer rental revenue grew 40.2% to $44.1 million and FFO rose 34.6% to $24.7 million, supported by 37 real-estate purchases. Segment income increased 32.3% to $12.1 million despite $5.1 million more interest expense.

  • Occupancy and acuity improved

    Occupancy rose to 82.9% from 81.3% a year earlier, while skilled mix by revenue increased to 50.0% from 49.2%. Same-facility occupancy reached 84.1%, up from 81.9%, supporting management's demand and acuity narrative.

  • Strong operating cash generation funds growth

    Six-month operating cash flow increased $44.2 million year over year to $272.1 million; less $88.3 million of property capex, implied free cash flow was $183.8 million. The company also deployed $376.0 million for acquisitions and repurchased $40.0 million of stock, with $60.0 million remaining authorized.

What to watch

  • High Medicaid exposure amid funding reform

    Medicaid represented 45.2% of Q2 revenue, leaving reimbursement exposed to Medicaid funding reform. The OBBB provides that grandfathered state-directed payments decline 10% annually beginning January 1, 2028, while the company says state-budget pressure could result in lower SNF reimbursement rates.

  • DOJ investigation and active claim reviews

    The DOJ's January 2024 Civil Investigative Demand covers Medicare and Texas Medicaid claims from January 1, 2016 to the present. Separately, 18 independent subsidiaries had multi-claim reviews scheduled or in process as of June 30, 2026, creating recoupment, fine, and reimbursement-risk exposure.

  • Acquisition spending reduced cash balance

    Cash and cash equivalents fell $241.6 million in the first six months to $262.3 million as investing outflows reached $478.9 million, including $376.0 million for acquisitions. While there were no credit-facility borrowings, the $600.0 million facility matures April 8, 2027 and fixed-rate mortgage/note debt totaled $142.3 million.

  • Litigation and labor-cost exposure

    A California wage-and-hour class/representative-action settlement for a six-year period ending December 2025 totals $12.0 million, pending court approval. A July 16, 2026 derivative complaint also seeks unspecified damages and governance reforms, with no amount accrued.

  • Rate and quality-reporting uncertainty

    CMS proposed a 2.4% net FY 2027 SNF payment-rate increase, composed of a 3.2% market-basket update less a 0.8% productivity adjustment, but the proposal remains subject to finalization. The company also notes that facilities failing SNF quality-reporting requirements can face a 2.0% payment reduction.

Management's outlook

The 10-Q contains no explicit updated annual revenue or EPS guidance. Management states that $262.3 million of cash, $268.6 million of investments, projected operating cash flow and available financing are expected to support normal operations for the foreseeable future; it also cites approximately $175.0 million of 2026 renovation-project spending budgeted.

Earlier filings 1

10-Q · April 30, 2026

The Ensign Group's Q1 2026 earnings report indicates a strong surge in revenue and earnings per share compared to both the prior quarter and the same period last year, driven by improved occupancy rates and successful…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.